R 196 (Clopidogrel bisulfate 75 mg (base))

Pill imprint R 196 has been identified as Clopidogrel bisulfate 75 mg (base).

Clopidogrel is used in the treatment of ischemic stroke; transient ischemic attack; peripheral arterial disease; ischemic stroke, prophylaxis; platelet aggregation inhibition (and more), and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Clopidogrel 75 mg (base) is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for R 196

Clopidogrel bisulfate 75 mg (base) R 196 Front
Clopidogrel bisulfate 75 mg (base) R 196 Back
Clopidogrel bisulfate
Imprint:
R
196
Strength:
75 mg (base)
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Platelet aggregation inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Dr.Reddy's Laboratories Limited
National Drug Code (NDC):
55111-0196
Inactive Ingredients:
silicon dioxide colloidal
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (5 mPa.s)
polyethylene glycol 400
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)